News & Updates

Show Multimedia Only
Colchicine touted for prevention of gout flare-ups after COVID-19 vaccination

Colchicine touted for prevention of gout flare-ups after COVID-19 vaccination

18 Mar 2022 byJairia Dela Cruz

Gout patients have about sixfold greater odds of experiencing a flare in the first few months after COVID-19 vaccination, but colchicine appears to keep these gout attacks at bay, as shown in a study from China.

Colchicine touted for prevention of gout flare-ups after COVID-19 vaccination

18 Mar 2022
HDL3 cholesterol tied to primary open-angle glaucoma

HDL3 cholesterol tied to primary open-angle glaucoma

18 Mar 2022

A causal and specific association exists between high-density lipoprotein (HDL) 3 cholesterol and primary open-angle glaucoma (POAG), suggests a cross-sectional study, noting that dysregulation of cholesterol transport may contribute to the pathogenesis of POAG.

HDL3 cholesterol tied to primary open-angle glaucoma

18 Mar 2022
Lower resilience tied to poorer medication adherence in glaucoma patients

Lower resilience tied to poorer medication adherence in glaucoma patients

18 Mar 2022 byStephen Padilla

The COVID-19 pandemic has worsened the adherence to ocular hypotensive medication among patients with primary open-angle glaucoma (POAG), according to a study. Such reduction is potentially driven by lower psychometric measures of resilience and more confrontational coping strategies.

Lower resilience tied to poorer medication adherence in glaucoma patients

18 Mar 2022
Booster COVID-19 vacc cuts breakthrough infection risk, particularly in individuals with no immune dysfunction

Booster COVID-19 vacc cuts breakthrough infection risk, particularly in individuals with no immune dysfunction

17 Mar 2022 byRoshini Claire Anthony

Receipt of a booster dose of the COVID-19 vaccine reduces the risk of breakthrough COVID-19 infections* compared to full vaccination only, particularly among individuals without immunosuppressed/compromised conditions (ISC), according to a US study presented at CROI 2022.

Booster COVID-19 vacc cuts breakthrough infection risk, particularly in individuals with no immune dysfunction

17 Mar 2022